Bingo, my friend! CBIS is in this very unique position in the US cannabis-pharma market. And for the long long term, they are in position to be the Kings of Canna when federal/FDA approval is achieved some day. Let's not lose site of the grand scheme, though news like 19 and the conference will provide little successes a long the way.